EpiPen manufacturer is accused of lax investigation into problems.
Sodium polystyrene sulfonate interferes with many oral drugs and should be dosed separately.
After trials halted, FDA issues warning on off-label use of the drug.
After Mylotarg was taken voluntarily taken off the market, the FDA is giving it a second chance.
The city's decision is the latest move against tobacco in pharmacies.
A petition sent by multiple groups says yes.
Mid Valley Pharmaceutical recalls two drugs.
Why the agency says the approval of Novartis’ new therapy is historic.
New therapies hold great promise—and great danger.
The recall is just the latest in a bacterial contamination scare.